Thomas E. Carey
Impact in
- Otorhinolaryngology top 0.02%
- Head and Neck Cancer Studies
- Cancer Research top 0.05%
- Cancer Genomics and Diagnostics
- Cancer-related molecular mechanisms research
Papers in
-
- Head and Neck Cancer Studies 177
-
- Cancer Genomics and Diagnostics 41
- Co-authors
- Carol Rossier Bradford (94 shared papers)Gregory T. Wolf (73 shared papers)Mark E. Prince (63 shared papers)Douglas Brian Chepeha (36 shared papers)Jonathan Brad McHugh (42 shared papers)Kenneth D. McClatchey (22 shared papers)Avraham Eisbruch (27 shared papers)Francis Paul Worden (28 shared papers)
- Journals
- Head & Neck (39 papers)Otolaryngology (20 papers)Cell Reports (12 papers)Nature Communications (12 papers)Clinical Cancer Research (11 papers)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Thomas E. Carey
381 papers receiving 45.6k citations
Thomas E. Carey's Hit Papers
Peers
Comparison fields: 5 of 184
- Otorhinolaryngology 7k
- Cancer Research 10.5k
- Oncology 8.7k
- Molecular Biology 12.6k
- Immunology and Allergy 678
Countries citing papers authored by Thomas E. Carey
This map shows the geographic impact of Thomas E. Carey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas E. Carey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas E. Carey more than expected).
Fields of papers citing papers by Thomas E. Carey
This network shows the impact of papers produced by Thomas E. Carey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas E. Carey. The network helps show where Thomas E. Carey may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas E. Carey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 383 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics Hit paper breakdown → | 2018 | 2633 |
| 2 | The repertoire of mutational signatures in human cancer Hit paper breakdown → | 2020 | 2401 |
| 3 | Oncogenic Signaling Pathways in The Cancer Genome Atlas Hit paper breakdown → | 2018 | 2371 |
| 4 | Pan-cancer analysis of whole genomes Hit paper breakdown → | 2020 | 2169 |
| 5 | Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer Hit paper breakdown → | 2018 | 1758 |
| 6 | Comprehensive Characterization of Cancer Driver Genes and Mutations Hit paper breakdown → | 2018 | 1748 |
| 7 | Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation Hit paper breakdown → | 2018 | 1634 |
| 8 | Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas Hit paper breakdown → | 2018 | 824 |
| 9 | Genomic and Functional Approaches to Understanding Cancer Aneuploidy Hit paper breakdown → | 2018 | 768 |
| 10 | Landscape of genomic alterations in cervical carcinomas Hit paper breakdown → | 2013 | 732 |
| 11 | The evolutionary history of 2,658 cancers Hit paper breakdown → | 2020 | 730 |
| 12 | Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974 Hit paper breakdown → | 2013 | 717 |
| 13 | Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients Hit paper breakdown → | 2018 | 696 |
| 14 | Targeted Gold Nanoparticles Enable Molecular CT Imaging of Cancer Hit paper breakdown → | 2008 | 695 |
| 15 | Pathogenic Germline Variants in 10,389 Adult Cancers Hit paper breakdown → | 2018 | 617 |
| 16 | Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines Hit paper breakdown → | 2018 | 598 |
| 17 | The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma Hit paper breakdown → | 2018 | 580 |
| 18 | Patterns of somatic structural variation in human cancer genomes Hit paper breakdown → | 2020 | 564 |
| 19 | EGFR, p16, HPV Titer, Bcl-xL and p53, Sex, and Smoking As Indicators of Response to Therapy and Survival in Oropharyngeal Cancer Hit paper breakdown → | 2008 | 520 |
| 20 | Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing Hit paper breakdown → | 2020 | 489 |
About Thomas E. Carey
Thomas E. Carey is a scholar working on Otorhinolaryngology, Cancer Research, Oncology, Immunology and Allergy and Sensory Systems, having authored 383 papers that have together received 46.5k indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (177 papers), Cancer Genomics and Diagnostics (41 papers), Cervical Cancer and HPV Research (38 papers), Genomic variations and chromosomal abnormalities (23 papers), Cell Adhesion Molecules Research (22 papers), Hearing, Cochlea, Tinnitus, Genetics (19 papers), Epigenetics and DNA Methylation (14 papers) and Cancer Cells and Metastasis (13 papers). The work is most often cited by research in Otorhinolaryngology (7k citations), Cancer Research (10.5k citations), Oncology (8.7k citations), Molecular Biology (12.6k citations) and Immunology and Allergy (678 citations). Thomas E. Carey has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Carol Rossier Bradford, Gregory T. Wolf, Mark E. Prince, Douglas Brian Chepeha, Jonathan Brad McHugh, Kenneth D. McClatchey, Avraham Eisbruch, Francis Paul Worden, Nisha J. D’Silva and Bhavna Kumar. Their work appears in journals such as Head & Neck, Otolaryngology, Cell Reports, Nature Communications and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.